These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3554759)

  • 1. The role of immunotherapy in type I diabetes mellitus.
    Geffner ME; Lippe BM
    West J Med; 1987 Mar; 146(3):337-43. PubMed ID: 3554759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Principles of immunotherapy in insulin-dependent diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific therapeutic attempts in experimental and clinical type-I diabetes.
    Federlin K; Becker F
    Klin Wochenschr; 1990; 68 Suppl 21():38-43. PubMed ID: 2198389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Will type I diabetes mellitus be treated with immunosuppressive drugs in the future?].
    Diem P
    Ther Umsch; 1993 Feb; 50(2):114-8. PubMed ID: 8456415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction and prevention of type 1 diabetes: progress, problems, and prospects.
    Skyler JS
    Clin Pharmacol Ther; 2007 May; 81(5):768-71. PubMed ID: 17392722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiology and pathogenesis of type I diabetes].
    Ziegler AG
    Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current views on the etiopathogenesis of type-I diabetes mellitus].
    Ricci M; Matucci A; Rossi O; Rotella CM
    Ann Ital Med Int; 1993; 8(3):153-65. PubMed ID: 8217479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the immunointervention of type-1 diabetes mellitus.
    Schernthaner G
    Horm Metab Res; 1995 Dec; 27(12):547-54. PubMed ID: 8750784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can insulin therapy delay or prevent insulin-dependent diabetes mellitus?
    Kakka R; Koda-Kimble MA
    Pharmacotherapy; 1997; 17(1):38-44. PubMed ID: 9017764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation for type 1 diabetes mellitus.
    Skyler JS
    Int J Clin Pract Suppl; 2010 Feb; (166):59-63. PubMed ID: 20377666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
    Reimers JI
    Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
    Phillips BE; Giannoukakis N; Trucco M
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and prevention.
    Giannoukakis N; Pietropaolo M; Trucco M
    Curr Opin Investig Drugs; 2002 May; 3(5):735-51. PubMed ID: 12090547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetics of Type 1 (insulin-dependent) diabetes.
    Cudworth AG; Wolf E
    Curr Probl Clin Biochem; 1983; 12():45-64. PubMed ID: 6418443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases.
    Sibley RK; Sutherland DE; Goetz F; Michael AF
    Lab Invest; 1985 Aug; 53(2):132-44. PubMed ID: 3894793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Unitarian Hypothesis for the aetiology of diabetes mellitus.
    Morrison EY; Ragoobirsingh D; Peter SA
    Med Hypotheses; 2006; 67(5):1115-20. PubMed ID: 16806731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells.
    Moustakas AK; Papadopoulos GK
    Am J Med Genet; 2002 May; 115(1):37-47. PubMed ID: 12116175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus.
    Liadis N; Murakami K; Eweida M; Elford AR; Sheu L; Gaisano HY; Hakem R; Ohashi PS; Woo M
    Mol Cell Biol; 2005 May; 25(9):3620-9. PubMed ID: 15831467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of genetic and non-genetic factors in type 1 diabetes.
    Hawa MI; Beyan H; Buckley LR; Leslie RD
    Am J Med Genet; 2002 May; 115(1):8-17. PubMed ID: 12116172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.